National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to continue treatment and follow-up of the participants recruited into the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study. GRADE is a pragmatic, unmasked clinical trial to compare commonly used diabetes medications, when combined with metformin, on long-term glucose-lowering effectiveness, with the main goal of providing guidance to clinicians about the most appropriate medications to treat type 2 diabetes.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV